Abstract: A Bacillus thuringiensis strain isolate, designated EG5144, exhibits insecticidal activity against coleopteran insects, including Colorado potato beetle and insects of the genus Diabrotica. A novel toxin gene in B.t. strain EG5144 produces an irregularly shaped insecticidal crystal protein of approximately 70 kDa that is toxic to coleopteran insects. The cryIII-type gene (SEQ ID NO:1), designated as the cryIIIC(b) gene, has a nucleotide base sequence illustrated in FIG. 1.
Type:
Grant
Filed:
March 15, 1993
Date of Patent:
November 23, 1993
Assignee:
Ecogen Inc.
Inventors:
Willam P. Donovan, Mark J. Rupar, Annette C. Slaney
Abstract: A purified and isolated cryIII-type gene was obtained from a novel B.t. strain. The gene has a nucleotide base sequence coding for the amino acid sequence illustrated in FIG. 1. The 74.4 kDa protein produced by this gene is an irregularly shaped crystal that is toxic to coleopteran insects, including Colorado potato beetle and insects of the genus Diabrotica.
Type:
Grant
Filed:
March 20, 1990
Date of Patent:
February 16, 1993
Assignee:
Ecogen Inc.
Inventors:
William P. Donovan, Mark J. Rupar, Annette C. Slaney, Timothy B. Johnson
Abstract: Purified endotoxin protein is recovered from aqueous suspensions containing lysed cells and Bacillus thuringiensis crystalline endotoxin protein in a multistep process.The aqueous suspension, e.g., a concentrated fermentation culture, is first treated under strongly basic or acidic conditions to solubilize the crystal protein and the solution is then separated from residual solids. Endotoxin protein is precipitated from the separated aqueous solution, by adjusting its pH to the isoelectric point of the protein, and recovered by centrifugation or the like.
Abstract: The present invention provides novel strains of Bacillus thuringiensis containing genes that code for P1 endotoxin proteins. The invention also provides methods and compositions for controlling insects or protecting plants from insect attack with a novel strain of Bacillus thuringiensis.
Type:
Grant
Filed:
November 7, 1988
Date of Patent:
September 15, 1992
Assignee:
Ecogen Inc.
Inventors:
Ivan E. Gard, Jr., Jose M. Gonzalez, Jr., Dennis R. Ciarlante
Abstract: The present invention relates to novel Bacillus thuringiensis transconjugant strains having improved insecticidal activity. The novel strains are produced by a combination of plasmid curing and conjugation of active strains.
Type:
Grant
Filed:
April 25, 1988
Date of Patent:
January 14, 1992
Assignee:
Ecogen Inc.
Inventors:
Jose M. Gonzalez, Jr., Anthony Macaluso
Abstract: The present invention relates to a purified and isolated gene having a nucleotide sequence coding for the amino acid sequence for the CryIIB protein (the nucleotide coding sequence being illustrated in FIG. 6 extending from nucleotides 874 through 2775).
Abstract: The present invention relates to an in vitro method for measuring the toxicity of a delta-endotoxin of Bacillus thuringiensis by evaluating the ability of said endotoxin to form an ion channel in a phospholipid vesicle.